Summarizing, and although we only conducted a relatively small cohort observational study, we demonstrated that COVID-19 patients with an increase of MIF levels (high inflammatory phenotypes) within three days after admission exhibited a higher mortality than those with a decline in MIF concentration (low-inflammatory phenotypes). This evidence concerns the gene MIF and COVID-19.